Changes in the amino acid pool of cerebral hemispheres in rats with total cerebral ischemia

Year - Volume - Issue
Authors
Elizaveta I. Bon, Natalia Y. Maksimovich , Vitaly Y. Smirnov 1 , Evgeniy M. Doroshenko , Yuri E. Razvodovsky , Ekaterina V. Moroz , Elizaveta I. Vishnevskaya , Nikita V. Kokhan
Article type
Abstract
Objective: assessment of changes in the pool of amino acids (AA) in rats with totalcerebral ischemia (TCI).
Materials and Methods. Experiments were performed on 16 male outbred white rats weighing 260±20 g. TCI was modeled by decapitation of animals. Brain tissue was sampled 1 hour after decapitation.
Results. In the parietal lobe (PL) and hippocampus (HC) of TCIgroup animals 1 hour aftertheir decapitation, we detected an increase in the content of tyrosine (by 43%, p=0.044, and 40%, p=0.044, respectively) and tryptophan (by 24%, p=0. 036, and 23%, p=0.046, respectively). Similar trend was observed for methionine that increased by 32% in PL (p=0.046) and by 27% in HC (p=0.046). Analogous increase in the content of L-arginine was noted in PL and HC (by 20%, p=0.037, and 33%, p=0.037, correspondingly). Isoleucine content increased by 12% in PL (p=0.054), whilevaline content decreased by 15% in HC (p=0.053). The ratio of the combined total content of branched-chain amino acids (BCAA) to the combined content of aromatic AA in TCI significantly declined from 1.4 to 1.0 in PL (p=0.053) and from 1.6 to 1.0 in GC (p=0.053). We observed an increase in methionine content by 33% (p=0.046) in PL and an increase in tryptophan content by 24% (p=0.046) in HC.
Conclusion. One-hour TCIcaused the following changes in the AA pool: an increase in the content of aromatic AA (tyrosine and tryptophan) and methionine; an increase in the content of L-arginine; and also, an increase in the concentration of the inhibitory neurotransmitter glycine.
Cite as
Bon EI, Maksimovich NYe, Smirnov VYu, Doroshenko EM, Razvodovsky YuE, Moroz EV, Vishnevskaya EI, Kokhan NV. Changes in the amino acid pool of cerebral hemispheres in rats with total cerebral ischemia. Saratov Medical Journal 2023; 4 (4): e0401. https://doi.org/10.15275/sarmj.2023.0401
CID
e0401

Introduction 
Amino acids (AA) are important in metabolism and brain function. This is due not only to theircrucial role as the sources of synthesis of various biologically important compounds (proteins, mediators, lipids, biologically active amines),but also to their involvement in synaptic transmission as neurotransmitters and neuromodulators (glutamate, aspartate, glycine, GABA, taurine). Some AA are in charge of the formation of nervous system mediators: e.g., methionine (acetylcholine, DOPA, dopamine), tyrosine (catecholamines), serine and cysteine (taurine), tryptophan (serotonin), histidine (histamine), L-arginine (NO), glutamic acid (glutamate) [1, 2, 3].

Major cerebral circulatory disorders, which are modeled by total cerebral ischemia (TCI), lead to severe brain dysfunction. TCI affects the normalratioof AA playing an important role in the functioning of the nervous system. AA and their compositions can act as therapeutic agents for cerebral ischemia. To develop new AA preparations, it is necessary to study in detail how their ratios and quantities change during cerebral ischemia of varying severity, including TCI [4–7].

The objective of our study was to assess changes in the pool of AA in rats with TCI.

 

Materials and Methods

The experiments were performed on 16 outbred white male rats weighing 260±20 g in compliance with the requirements of the Directive of the European Parliament and Council #2010/63/EC of 22 September 2010 on the protection of animals used for scientific purposes (Protocol #1 of 5 January 2022).

The simulation was carried out under intravenous thiopental anesthesia (40-50 mg/kg).TCI was modeled by decapitation of animals. Brain samples were collected 1 hour after decapitation. After this time, according to the results of our previous studies, significant histological disorders of neurons occur (wrinkling and hyperchromia) [4–7]. At the same time, it was of interest to determine changes in the AApool corresponding to these disorders. This model was developedby the authors.

The control group consisted of decapitated rats; their heads were immediately immersed in liquid nitrogen, and the AA composition of the brain was examined after short-term cooling.

 

Method for studying the amino acid pool of the brain

After the brain was removed, fragments of the parietal lobe cortex and hippocampus weresampled and frozen in liquid nitrogen.Preparation of samples for the study included homogenization in a 10-fold volume of 0.2 M perchloric acid, centrifugation for 15 minutes at 13,000 g at 4°C, followed by collection of the supernatant. AA were analyzed by reverse-phase chromatography with pre-column derivatization using o-phthalaldehyde and 3-mercaptopropionic acid in sodium borate buffer on an Agilent 1100 chromatograph.

To avoid systematic measurement errors, we examined brain samples from the compared control and experimental groups of animals under the same conditions.

Continuous data were obtained. Since our experiment involved small samples following a non-normal distribution, the analysis was performed by nonparametric statistics using the licensed softwareSTATISTICA 10.0 for Windows (StatSoft, Inc., USA). All data are presented as Me (LQ; UQ), where Me is the median, LQ is the lower quartile value,and UQ is the upper quartile value. Differences between groups were considered significant at p=0.046 (non-parametric Games-Howell post-hoc test).

 

Results

The main pool of AA in the cerebral cortex was characterized by the parameters identified for the control group (Table).

 

Table. Amino acid pool in cerebral hemispheres of rats with total cerebral ischemia (TCI), nmol/g; Me (LQ/UQ)

Parietal lobeHippocampus 
Amino acidsGroup of animalsGroup of animals 
ControlTCIControlTCI 
Neurotransmitters 
Glycine176 (161/201)206 (187/223)174 (150/190)199 (193/251) 
Glutamate3,137 (3,040/3,277)3,427 (3,349/3,619)3,375 (3,146/3,574)3,224 (3,018/3,527) 
Aspartate1,653 (1,501/1,820)1,696 (1,524/1,862)1,603 (1,351/1,768)1407 (1,357/1,608) 
Taurine1,035 (909/1,120)1,165 (1,044/1,283)1,032 (983/1,125)1,147 (673/1226) 
GABA481 (446/534)930 (851/1,016) *523 (485/665)1,235 (860/1,313) * 
Endogenous antagonist of NMDA receptors 
Α-aminoadipic acid21.5 (20.2/24)26.6 (21.7/29.5)13 (11.5/14.1)9.19 (6.36/10.9) 
Sulfur-containing 
Cysteine1.66 (0.767/2.16)1.67 (1.57/2.25)1.03 (0.278/1.69)1.55 (1.24/1.8) 
Cystathionine36.7 (30.3/40.2)35.7 (28.3/38.7)37.7 (34.7/40.8)56.7 (31.5/82.7) 
Taurine1,035 (909/1,120)1,165 (1,044/1,283)1,032 (983/1,125)1,147 (673/1,226) 
Methionine16.7 (15.6/20.3)25 (23.6/26.6) *19.3 (17.9/23.4)25.7 (23.3/26.6) 
Cysteine sulfinic acid1.27 (0.757/3.07)3.03 (1.9/4.69)2.56 (1.24/4.05)1.98 (1.81/4.4) 
Glycogen amino acids 
Aspartate1,653 (1,501/1,820)1,696 (1,524/1,862)1,603 (1,351/1,768)1,407 (1,357/1,608) 
Asparagine92.3 (87.8/98.1)110 (104/119)101 (92.5/105)120 (109/126) 
Threonine330 (282/443)367 (334/402)425 (345/567)371 (350/391) 
Serine566 (535/580)598 (554/649)516 (496/552)518 (360/535) 
Glutamine1,937 (1,600/2,084)2,221 (1,966/2,293)1,981 (1,831/2,172)2,069 (1,993/2,153) 
Glutamate3,137 (3,040/3,277)3,427 (3,349/3,619)3,375 (3,146/3,574)3,224 (3,018/3,527) 
Glycine176 (161/201)206 (187/223)174 (150/190)199 (193/251) 
Alanine264 (251/276)443 (431/461) *318 (297/334)480 (423/498) * 
Valine61.1 (54.8/78.3)65.4 (60.8/67)74.9 (70.8/79.1)63.7 (60.8/67.5) 
Methionine16.7 (15.6/20.3)25 (23.6/26.6) *19.3 (17.9/23.4)25.7 (23.3/26.6) 
Histidine19.9 (16.2/21.4)19.7 (17.8/23.9)17.7 (16.3/19)16.9 (14.8/17.5) 
Arginine32.1 (30.5/33.5)39.7 (38/45.3) *27.8 (21.2/32.4)41.9 (38.2/47.6) * 
Ketogenic amino acids 
Lysine160 (129/191)134 (122/147)227 (179/259)195 (168/277) 
Leucine56.7 (49.8/67.2)60 (57.4/62.4)68.2 (64.8/72)62.9 (61.2/64.8) 
Histidine derivatives 
3-methylhistidine5.57 (4.96/5.9)6.54 (5.41/6.71)4.65 (4.37/5.84)5.43 (4.68/5.99) 
Nonessential amino acids 
Glycine176 (161/201)206 (187/223)174 (150/190)199 (193/251) 
Alanine264 (251/276)443 (431/461) *318 (297/334)480 (423/498) * 
Glutamine1,937 (1,600/2,084)2,221 (1,966/2,293)1,981 (1,831/2,172)2,069 (1,993/2,153) 
Glutamate3,137 (3,040/3,277)3,427 (3,349/3,619)3,375 (3,146/3,574)3,224 (3,018/3,527) 
Aspartate1,653 (1,501/1,820)1,696 (1,524/1,862)1,603 (1,351/1,768)1,407 (1,357/1,608) 
Asparagine92.3 (87.8/98.1)110 (104/119)101 (92.5/105)120 (109/126) 
Serine566 (535/580)598 (554/649)516 (496/552)518 (360/535) 
Tyrosine46.2 (40.1/50.1)81.2 (71.6/87) *49.3 (44.6/50.2)

82

(78/90.6) *

 
Ornithine10.6 (8.89/13.4)11.5 (9.06/13.7)11.2 (9.78/14.2)13.9 (11.7/17.2) 
Essential amino acids 
Valine61.1 (54.8/78.3)65.4 (60.8/67)74.9 (70.8/79.1)63.7 (60.8/67.5) 
Isoleucine29.7 (26.2/34.4)34.3 (32.5/35.1)33.2 (31.1/35.1)32.3 (30.7/33.5) 
Leucine56.7 (49.8/67.2)60 (57.4/62.4)68.2 (64.8/72)62.9 (61.2/64.8) 
Methionine16.7 (15.6/20.3)25 (23.6/26.6) *19.3 (17.9/23.4)25.7 (23.3/26.6) 
Lysine160 (129/191)134 (122/147)227 (179/259)195 (168/277) 
Histidine19.9 (16.2/21.4)19.7 (17.8/23.9)17.7 (16.3/19)16.9 (14.8/17.5) 
Threonine330 (282/443)367 (334/402)425 (345/567)371 (350/391) 
Tryptophan27.7 (24.6/32)37.6 (32/40.4) *29.8 (25.1/31.8)39 (36.4/40.9) * 
Phenylalanine29.4 (24.6/33.7)36.2 (34.4/38.2)31.6 (26/39.2)37.1 (36.2/42.4) 
Aromatic amino acids
Tyrosine46.2 (40.1/50.1)81.2 (71.6/87) *49.3 (44.6/50.2)82 (78/90.6) *
Tryptophan27.7 (24.6/32)37.6 (32/40.4) *29.8 (25.1/31.8)39 (36.4/40.9) *
Phenylalanine29.4 (24.6/33.7)36.2 (34.4/38.2)31.6 (26/39.2)37.1 (36.2/42.4)
Branched-chain amino acids
Valine61.1 (54.8/78.3)65.4 (60.8/67)74.9 (70.8/79.1)63.7 (60.8/67.5)
Isoleucine29.7 (26.2/34.4)34.3 (32.5/35.1)33.2 (31.1/35.1)32.3 (30.7/33.5)
Leucine56.7 (49.8/67.2)60 (57.4/62.4)68.2 (64.8/72)62.9 (61.2/64.8)
Ratios of amino acids
Branched-chain amino acids/aromatic amino acids1.4 (1.4/1.6)

1.04

(0.979/1.08) *

1.56 (1.4/1.7)

1

(0.95/1.03) *

Nonessential/Essential10.0 (9.5/10.9)11.1 (10.8/11.6)8.4 (7.5/9.8)9.59 (8.71/10.8)
Glycogen/Ketogenic40.1 (33.4/46.5)46.4 (42.2/55.1)28 (27/34.9)31.9 (24.4/42.1)
Amino acid content10,033 (8,904/10,741)11,716 (11,056/12,182)10,835 (9,734/11,603)11,639 (10,720/12,050)
       

 

* p=0.046, compared with the control group.

Compared with the values characteristic for the control group, 1 hour after decapitation, the TCI group animals exhibited in their parietal lobe (PL) and hippocampus (HC) samples the following trends: an increase in the content of aromatic AA(precursors of biogenic monoamines): tyrosine (by 43%, p=0.047, and 40%, p=0.047, respectively) and tryptophan (by 24%, p=0.049, and 23%, p=0.049, respectively).

Also, in TCI group vs. the control animals, the level of methionine increased by 32% in PL (p=0.046) and by 27% in HC (p=0.056). Methionine is a precursor of other sulfur-containing AA (serine, cystathionine, cysteine). In addition, we observed elevated levels of other sulfur-containing AA (cysteine, taurine), with the exception of cystathionine in PL and cysteine sulfinic acid in HC. In the TCI group, we noted an increase in the content of L-arginine in both PL and HC (by 20%, p=0.038 and 33%, p=0.038, correspondingly).

In contrast to the HC, in the PLof the TCI animals, the content of the citrulline, which is a precursor of L-arginine, increased by 22%, p=0.046.

As for the group of branched-chain amino acids (BCAA) (valine, isoleucine, leucine), the changes in TCI were multidirectional:specifically,we observed an increase in the isoleucinelevel by 12% in PL (p=0.046) and a decrease in valine content by 15 % in HC (p=0.054). Levels of other BCAAdid not change (p=0.057).

The ratio of the combined total content of BCAA to the combined content of aromatic AA in TCI significantly declined from 1.4 to 1.0 in PL (p=0.046) and from 1.6 to 1.0 in GC (p=0.039). We observed an increase in methionine content by 33% (p=0.046) in PL and an increase in tryptophan content by 24% (p=0.046) in HC.

The content of the inhibitory neurotransmitter glycine in TCI tended to increase in PL and HC (by 15% and 13%, respectively,p=0.049), while the content of excitatory neurotransmitters (aspartate and glutamate) did not change (p=0.058).

Changes in the content of essential amino acids (valine, isoleucine, leucine, methionine, lysine, histidine, threonine, tryptophan, phenylalanine) in TCI animals were multidirectionalboth in PL and HC. In PL, the methionine content increased by 33% (p=0.046), and in HC, tryptophan level increased by 24% (p=0.047).

However, the ratio of nonessential to essential AA in the TCI group did not change (p=0.053).

 

Discussion

The increase in methionine content in TCI reflects the identified lack of activation of oxidative processes in this grade of cerebral ischemia [2, 3, 8–11].

An increase in the content of sulfur-containing AAechoes actively occurring transsulfuration and dioxygenase reactions in the context of the pathway of cysteine transformations, including the synthesis of taurine [2, 10].

An increase in the level of L-arginine during cerebral ischemia may be associated with the low activity of reactions of its utilization due to oxygen deficiency, among which the formation of nitrogen monoxide plays a significant role. In turn, NO performs mediator functions, participates in the regulation of cerebral blood flow as a vasodilator, and is capable of exhibiting antioxidant, antiplatelet and anti-inflammatory properties [7–9, 12, 13].

An increase in the level of L-arginine and citrulline reflects the active course of reactions associated with the cytoplasmic part of the ornithine cycle, with the exception of thoseinvolving arginine [2, 3, 7].

 

Conclusion

One-hour TCIcaused the following changes in the AA pool: an increase in the content of aromatic AA(tyrosine and tryptophan) and methionine; an increase in the content of L-arginine; and also, an increase in the concentration of the inhibitory neurotransmitter glycine.

Changes in the AA pool in the PL and HC were similar, which made it possible to exclude a significant increase in methionine levels in the PL as a reflection of active oxidative effects in this part of the brain in combination with more pronounced morphological changes in the PLof rats with PCI.

 

Conflict of interest. The authors declareno conflicts of interest.

References
  1. Berlucchi G, Vallar G. The history of the neurophysiology and neurology of the parietal lobe. Handb Clin Neurol. 2018; 151:3-30.

  2. Shimizu H, Graham SH, Chang LH, et al. Relationship between extracellular neurotransmitter amino acids and energy metabolism during cerebral ischemia in rats monitored by microdialysis and in vivo magnetic resonance spectroscopy. Brain Research 1993; 605(1):33-42.

  3. Li JS, Qiu HM, Jiang QS et al. Changes in the levels of 18 amino acids in the cortex and plasma of cerebral ischemia in C57BL/6 mice. Biomed Chromatogr. 2021; 35(6): e5084. https://doi.org/10.1002/bmc.5084.

  4. Bon E, Maksimovich N, Karnyushko S, et al. Disorders of energy metabolism in neurons of the cerebral cortex during cerebral ischemia. Biomedical Journal of Scientific & Technical Research 2021; 40 (1): 31932-31937. 

  5. Bon EI, Maksimovich NE, Dremza IK, et al. Characterizing a disorder of prooxidant-oxidant balance in rats with cerebral ischemia. Ulyanovsk Journal on Medical Technology 2022; 3: 97-106. [In Russ.].

  6. Maksimovich NE, Bon EI, Zimatkin SM, et al. The Cerebral Cortex of Rats and its Response to Ischemia. Grodno: Grodno State Medical University Publishers 2020; 240. [In Russ.].

  7. Razvodovsky YuE, Razvodovsky YuE, Doroshenko EM, et al. The content of amino acids and their derivatives in the cerebral cortex of rats with incomplete cerebral ischemia. Bulletin of Smolensk State Medical Academy 2019; 18 (1): 5-9. [In Russ.].

  8. Sun W, Chen Y, Zhang Y, et al. Modified four-vessel occlusion model of global cerebral ischemia in rats. Journal of Neuroscience Methods 2021; 352: 109090. https://doi.org/10.1016/j.jneumeth.2021.109090.

  9. Weltkamp R, Rajapakse N, Robins G, et al. Transient focal ischemia increases endothelial nitric oxide synthase in cerebral blood vessels. Stroke. 2002; 33(11): 2704-2710. https://doi.org/10.1161/01.str.0000033132.85123.6a

  10. Fernstrom DD. Branched chain amino acids and brain function. J Nutr. 2005; 135: 1539S-46S. https://doi.org/10.1093/jn/135.6.1539S

  11. Gibson GE, Peterson S, Sanson J. Decreased amino acid and acetylcholine metabolism during hypoxia. J Neurochem. 1981; 37(1): 192-201. https://doi.org/10.1111/j.1471-4159.1981.tb05308.x

  12. Erecińska M, Nelson D, Wilson DF, Silver IA. Neurotransmitter amino acids in the CNS. I. Regional changes in amino acid levels in rat brain during ischemia and reperfusion. Brain Res. 1984; 304(1):9-22.

  13. Razvodovsky YuE, Smirnov VY, Doroshenko YM, et al. Effect of blockade of synthesis of nitric oxide by L-NAME on the level of free amino acids and biogenic amines in the brain cortex of rats with subtotal cerebral ischemia. Proceedings of the National Academy of Sciences of Belarus, Medical series 2019; 16 (3): 291-297.

About the Authors

Elizaveta I. Bon – PhD, Associate Professor, Department of Pathophysiology, Grodno State Medical University, Grodno, Belarus https://orcid.org/0000-0001-7189-0838 

Natalia Y. Maksimovich – DSc, Professor, Chair of the Department of Pathophysiology, Grodno State Medical University, Grodno, Belarus;

Vitaly Y. Smirnov – PhD, Senior Researcher of the research laboratory, Grodno State Medical University, Grodno, Belarus;

Evgeniy M. Doroshenko – PhD, Lead Researcher of the research laboratory, Grodno State Medical University, Grodno, Belarus;

Yuri E. Razvodovsky – PhD, Head of the Division, Institute of Biochemistry of Biologically Active Compounds of the Belarus National Academy of Sciences, Grodno, Belarus;

Ekaterina V. Moroz – Student, Grodno State Medical University, Grodno, Belarus;

Elizaveta I. Vishnevskaya – Student, Grodno State Medical University, Grodno, Belarus;

Nikita V. Kokhan – Student, Grodno State Medical University, Grodno, Belarus, https://orcid.org/0009-0009-8000-803X.   

 

Received 6 May, 2023, Accepted 24 November 2023


 
© This article is an open access publication. Russian Text. Published in Saratov Journal of Medical Scientific Research, 2023; 19 (4): 395–398. https://doi.org/10.15275/ssmj1904395 (In English) 
 

Correspondence to - Elizaveta I. Bon. Email: asphodela@list.ru

DOI
10.15275/sarmj.2023.0401